GZMB and ovarian serous cystadenocarcinoma: Prognostic correlation analysis showed that the GZMB was negatively correlated with survival in BLCA, BRCA, CESC, ovarian serous cystadenocarcinoma (OV), skin cutaneous melanoma (SKCM), UCEC, and uveal melanoma (UVM).